Medifast® Q3 2025 Earnings Supplement © 2025 Medifast, Inc. All Rights Reserved. 2 Medifast® Q3 2025 Highlights Revenue and EPS at upper end of guidance range Safe Harbor Statement This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by use of phras ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Insights - Adia Nutrition has reported an extraordinary revenue growth of over 200% in Q3 compared to the previous quarter, alongside a net profit margin exceeding 20% [2] - The early release of Q3 financial results reflects the company's commitment to transparency and operational excellence, positioning it as a leader in the health and wellness industry [1][2] Financial Performance - The company achieved revenue growth of over 200% compared to the prior quarter, surpassing previously forecasted financial targets [2] - The net bottom-line profit margin for Q3 exceeded 20%, indicating strong financial health and effective cost management [2] Strategic Initiatives - Adia Nutrition is focused on expanding its product portfolio and creating value for customers and stakeholders through innovative strategies [2] - The company is actively seeking strategic partnerships with clinic owners and healthcare practitioners to license the Adia Med name and integrate regenerative therapies into their practices [3] Company Overview - Adia Nutrition Inc. specializes in stem cell and regenerative products, operating through its lab division, AdiaLabs LLC, and expanding its network of Adia Med clinics [4] - The company generates revenue through service fees, product sales, equity stakes, and insurance billing for healthcare treatments [5] - Adia Nutrition is committed to advancing healthcare through innovation and standardized, FDA-approved lab protocols [5]

Core Insights - WW International's share price increased by over 9% following the announcement of a collaboration with Amazon Pharmacy for distributing weight-management medications [1][2] - The partnership aims to simplify and expedite access to weight management medications for customers, as stated by the company's COO [3] - No specific estimates were provided regarding the financial impact of the Amazon deal, but it is expected to positively influence revenue and profitability [4] Company Developments - WW International signed a distribution agreement with Amazon Pharmacy to distribute its weight-management medications [2][6] - The company began offering compounded GLP-1 weight loss drugs under a subscription program in October 2024 [3] - The collaboration with Amazon is seen as a significant addition to the company's distribution channels for its products [4] Market Context - The stock performance of WW International outpaced the S&P 500, which saw a 1.1% increase on the same day [1] - Despite the positive stock movement, analysts from The Motley Fool Stock Advisor did not include WW International in their list of top investment recommendations [5][6]

Group 1 - Hims & Hers Health (HIMS) has established a cup-with-handle base, presenting a buy point at 60.55 [1] - The stock has experienced a significant surge of 126% year-to-date as of Monday [1] - Hims stock has been selected for IBD 50 Stocks To Watch, indicating strong market interest [1] Group 2 - The current market environment shows indexes near record highs as October begins [2]

Industry Overview - The health and fitness industry has transitioned from a niche market to a global growth engine, driven by a cultural emphasis on healthier living and proactive self-care [2] - Consumers are increasingly seeking balanced nutrition, structured fitness routines, and comprehensive wellness solutions, leading to a growing demand for gyms, supplements, and tailored programs [2] - The global health and wellness market is projected to reach $11 trillion by 2034, with a compound annual growth rate (CAGR) of 5.4% from 2025 [4] Role of Technology - Technology giants like Apple and Amazon are significantly influencing the health and fitness landscape through innovations such as the Apple Watch, Fitness+ platform, and One Medical [3] - These technologies are merging fitness, healthcare, and daily life, enhancing consumer engagement and driving industry growth [3] Key Companies United Natural Foods (UNFI) - UNFI offers a diverse portfolio of nearly 230,000 products focused on health and wellness, including natural, organic, and personal care items [7] - The company has invested in organic certification and sustainability, with 33 U.S. distribution centers registered as Organic Handlers [8] - UNFI's digital platforms support emerging wellness brands, and its foundation promotes regenerative agriculture and nutrition education [9] American Well Corporation (Amwell) - Amwell is a digital healthcare platform that provides telehealth services and integrates various healthcare offerings through its Converge platform [10] - The company has evolved from traditional telehealth to a holistic digital care model, focusing on chronic disease management and wellness initiatives [11] - Amwell has improved its financial position through cost reductions and innovation, aiming to be a leader in digital wellness [12] SunOpta - SunOpta specializes in plant-based and fruit-based products, catering to the demand for minimally processed foods [13] - The company has shifted towards higher-margin categories and emphasizes sustainability in its sourcing and production practices [15] - Recent innovations include expanding its plant-based and organic product portfolio to align with consumer health values [15] Peloton Interactive - Peloton has developed a connected fitness platform that combines advanced equipment with immersive digital content and community engagement [16] - The company has transitioned from a hardware-centric model to a balanced approach of product sales and recurring subscription revenues [17] - Peloton continues to innovate by expanding its content library and exploring international markets, positioning itself for long-term growth in the fitness sector [19]

Core Insights - Over 90% of U.S. adults are classified as metabolically unhealthy, indicating a growing crisis of metabolic dysfunction [1] - Metabolic dysfunction is associated with various challenges, including being overweight and difficulties in maintaining energy and long-term health [1] - Medifast, a health and wellness company with over 40 years of experience, is focusing on addressing this issue through its science-backed, coach-guided lifestyle system [1]

Core Viewpoint - Aja Health and Wellness Inc. is working towards filing its annual audited financial statements for the year ending December 31, 2024, and its unaudited interim financial statements for the three months ended March 31, 2025, after facing delays due to a reverse takeover transaction [2][3]. Group 1: Financial Filings - The Alberta Securities Commission issued a Failure-to-File Cease Trade Order (FFCTO) on August 1, 2025, due to the company's inability to meet filing deadlines for the Annual and Interim Filings [2]. - The delay in filing the Annual Filings is attributed to the need for a valuation of the purchase price allocation related to the reverse takeover transaction that closed on September 17, 2024 [3]. - The company expects to finalize the Annual Filings by September 30, 2025, pending the completion of the valuation [3][4]. Group 2: Future Expectations - Aja anticipates that the FFCTO will remain in effect until the Annual and Interim Filings are submitted [4]. - The company is actively working to complete the Interim Filings and aims to file them by September 30, 2025 [4].

Core Insights - Limitless X Holdings, Inc. has launched a new Investor Relations website to enhance transparency and communication with investors [1][2] - The company operates through various subsidiaries in Health and Wellness, Film and Television Production, Sports Media, Digital Assets, and Lifestyle Real Estate, positioning itself for multi-vertical growth [1][2][4] Investor Relations Website Features - The new Investor Relations site provides centralized access to financials, shareholder letters, governance, and updates across all operating divisions [1][2] - It aims to empower investors by consolidating shareholder communications, financial reporting, and strategic insights [2][6] Company Overview - Limitless X Holdings is focused on creating a high-growth, value-driven ecosystem that promotes health, wellness, entertainment, and lifestyle innovation [4] - The company is expanding its Direct-to-Consumer eCommerce platform and developing wellness-centered communities and premium lifestyle destinations [4] Strategic Goals - Limitless X is positioned for aggressive international expansion and exceptional customer engagement through a strengthening global distribution network and strategic partnerships [4] - The company emphasizes long-term value creation and transparency in its operations [2][4]

Core Insights - Hims & Hers Health, Inc. (HIMS) is a consumer-first health and wellness platform that connects patients with licensed healthcare professionals, focusing on personalized and accessible care [1][2] - The company reported over 2.4 million subscribers in Q2 2025, with 1.5 million receiving personalized treatment, showcasing its commitment to holistic health solutions [2][7] - HIMS is expanding into new health domains such as hormonal health and longevity through acquisitions, aiming to promote preventive and personalized wellness [3][7] Company Performance - Hims & Hers shares have increased by 75.1% year to date, significantly outperforming the industry growth of 21.6% [6] - The Zacks Consensus Estimate for HIMS' 2025 earnings per share indicates a 122.2% improvement from 2024 [8] Financial Metrics - HIMS' forward 12-month price-to-sales (P/S) ratio is 3.6X, lower than the industry's average of 5.7X but higher than its three-year median of 2.4X [10] - The consensus estimates for HIMS' earnings per share for the current quarter, next quarter, current year, and next year are 0.09, 0.12, 0.60, and 0.80 respectively, with significant year-over-year growth expected [11]